CD4 and stroke disorder: Li et al. [33] found that, in stroke patients, various regulatory immune subpopulations—including CD4+ and CD8+ regulatory T cells, B regulatory cells (Bregs), and double-negative T cells (DNTs) dynamically predicted neurological outcomes, weighing the prognostic relevance of immune regulation in cardiovascular disease.